Streetbeat News

Products Services

CF Industries Holdings anticipates a constructive global nitrogen supply-demand balance in the near term and expects the balance to tighten in the medium term.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:35 pm

CGAU

IPX

RGLD

Royal Gold, Inc. (RGLD) has extended its agreement with Centerra Gold Inc. (CGAU) for the Mount Milligan Mine until 2035, involving $125 million in cash and gold. Reliance Steel & Aluminum Co. (RS) is set to acquire American Alloy Steel, Inc., enhancing its value-added processing capabilities. IperionX Limited (IPX) is advancing in its efforts to scale titanium production, with significant developments in its manufacturing capabilities.

Portfolio Pulse from Austin DeNoce

February 14, 2024 | 9:32 pm

CELU

Celularity Inc. announced its technology for treating limbal stem cell deficiency (LSCD) will be presented at the World Biomaterials Congress. The study investigates a product combining human amniotic membrane and stem cells for ocular surface disorders. This highlights Celularity's advancements in regenerative medicine and potential for treating LSCD, a significant clinical opportunity.

Portfolio Pulse from Happy Mohamed

February 14, 2024 | 9:32 pm

HSY

LDSVF

MDLZ

Cocoa prices have surged over 100% in the past year, reaching over $5,500 per tonne due to supply challenges in West Africa, particularly from Ivory Coast and Ghana. This increase is attributed to diseases and adverse weather conditions, along with rising freight rates amid tensions in the Red Sea area. The U.S., being the largest chocolate market, is affected, with companies like Mondelez International Inc. (MDLZ), The Hershey Company (HSY), and Lindt & Sprüngli AG (LDSVF) potentially facing higher costs.

Portfolio Pulse from Piero Cingari

February 14, 2024 | 9:30 pm

SSNC

SS&C Technologies Holdings, Inc. (SSNC) has entered into a long-term agreement with DDH Graham, an Australian investment management firm. Under this agreement, DDH Graham will utilize SS&C's financial administration and technology resources on a sub-contracting basis. The transition of administration services to SS&C is expected to occur over the next few months.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 9:20 pm

SHIBUSD

Shiba Inu (CRYPTO: SHIB) is close to increasing its value significantly, with the lead developer's cryptic messages hinting at upcoming news. The community is abuzz with speculation, especially with the recent increase in network activity and the number of active and new accounts on the Shibarium platform. Shiba Inu's price is up 3.6% in the past 24 hours, and it's only 2.5% away from reaching a new price milestone. This surge in interest and adoption could potentially lead to a price spike soon.

Portfolio Pulse from Khyathi Dalal

February 14, 2024 | 9:06 pm

TVGN

Tevogen Bio Holdings Inc. has completed a business combination with Semper Paratus Acquisition Corporation and will be listed on Nasdaq under the ticker 'TVGN'. This move is expected to increase Tevogen's access to capital, accelerating the development of its off-the-shelf T cell therapy products for virology, oncology, and neurology. The company's innovative platform aims to address unmet needs in large patient populations with a focus on affordability and advanced science.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 8:56 pm

CMCSA

DIS

DKNG

NKE

PARA

Tiger Woods returns to the PGA Tour at the Genesis Invitational after ending his partnership with Nike and launching a new apparel brand, Sun Day Red. The event, where Woods has historically struggled but is a longshot favorite, will be broadcasted by The Walt Disney Company, Paramount Global, and Comcast Corporation. Betting odds from DraftKings show Woods as a longshot to win, with various payouts for different finishes.

Portfolio Pulse from Chris Katje

February 14, 2024 | 8:22 pm

AMD

META

NVDA

TSLA

Susquehanna analyst Christopher Rolland reiterated a Positive rating on Nvidia Corp (NVDA) with a price target of $850, up from $625, ahead of its earnings report on February 21. Rolland expects strong results and guidance, particularly from Data Center GPUs, with solid demand from AI, supported by Meta Platforms Inc (META) and Tesla Inc (TSLA). He also anticipates in-line to slightly better Gaming segment performance, citing data from Advanced Micro Devices, Inc (AMD). However, he flagged concerns over weaker Chinese EV demand impacting Nvidia's Auto segment. Rolland's revenue expectations for Nvidia are $21.5 billion for the fourth quarter, $23 billion for the first quarter, and $99 billion for fiscal 2025.

Portfolio Pulse from Anusuya Lahiri

February 14, 2024 | 8:16 pm

BIIB

ESALY

NVS

Biogen Inc (NASDAQ:BIIB) reported Q4 2023 sales of $2.39 billion, missing estimates and showing a 6% Y/Y decline. Adjusted EPS also fell by 27%. The company's partner, Eisai Co Ltd (OTC:ESALY), faces delays with Leqembi's patient enrollment, impacting Biogen's stock growth. Baird analyst lowered Biogen's price target to $316 from $333 but maintained an Outperform rating. Competition in Spinal Muscular Atrophy treatments from Novartis AG (NYSE:NVS) and Roche's Genentech affects Biogen's Spinraza. Biogen may pursue $1B-$2B deals to fill revenue gaps, focusing on the CNS space.

Portfolio Pulse from Vandana Singh

February 14, 2024 | 8:11 pm